Ypsomed Holding AG (YPSN.SW)

CHF 365.0

(-0.14%)

Market Cap (In CHF)

4.97 Billion

Revenue (In CHF)

548.45 Million

Net Income (In CHF)

78.36 Million

Avg. Volume

11.33 Thousand

Currency
CHF
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
287.5-439.0
PE
-
EPS
-
Beta Value
0.97
ISIN
CH0019396990
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Simon Michel
Employee Count
-
Website
https://www.ypsomed.com
Ipo Date
2004-09-22
Details
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates in two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, patch injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through biotechnology and pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.